GRCU Updated: 03-27-2017 $GRCU Last Trade: 3/24/2017

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
88
GRCU Updated: 03-27-2017 $GRCU
Last Trade: 3/24/2017 3:51:00 PM
Last 0.018   +0.002 +12.50%
Open 0.016
Previous Close 0.016
Day High / Low 0.020 / 0.015
Year High / Low - / -
Volume 2,971,660
Projected Volume 2971660 (207%)
# of Trades / Projected 63 / 63
Dividend / Yield - / -
Abnormal Activity ABNORMAL DAY UP
Abnormal Volume NO
Gap NONE
Candle BULLISH
Volatility Today LOW
Volatility Yesterday LOW
Price Relativity
From 40 Day High 64%
From 80 Day High 43%
From 150 Day High 37%
From 40 Day Low 115%
From 80 Day Low 115%
From 150 Day Low 225%
Pivot Analysis
Price Pivot $ 0.020
Day Resistance 1 $ 0.020
Day Support 1 $ 0.020
Day Resistance 2 $ 0.020
Day Support 2 $ 0.010
Consolidations
Short Term YES
Medium Term YES
Long Term YES
Volume Indicators
20 Day Avg Vol 1,433,008
Today / 20 Day Avg Vol ABOVE
150 Day Avg Vol 3,100,691
Today / 150 Day Avg Vol BELOW
Abnormal Volume NO
William Volume Accumulation bearish
Volume Price Trend bearish
Momentum Indicators
10 Day Trend bearish
40 Day Trend bearish
100 Day Trend bearish
Stochastics neutral
RSI bearish
MACD bearish
Moving Average Indictors
15 Day Trend bearish
45 Day Trend bearish
100 Day Trend bearish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? ABNORMAL DAY UP
Volatility Index Today LOW
Volatility Index Yesterday LOW
10 Day Volatility DECREASING
20 Day Volatility DECREASING
40 Day Volatility DECREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

AnaptysBio's Upcoming Investor Conference Schedule Explained

Updated Category News Views 181

Overview of AnaptysBio's Investor Engagement AnaptysBio, Inc. (NASDAQ: ANAB), based in San Diego, is recognized in the biotechnology sector for its commitment to advancing immunology therapies. This clinical-stage company focuses on tackling autoimmune disorders and inflammatory diseases through innovative therapeutics. Recently, AnaptysBio's president and CEO, Daniel...

Continue Reading
Truist Q2 2026 Earnings: Key Highlights and Insights

Updated Category News Views 12

Truist's Big Second Quarter Reveal Boy, isn't it just the way, you blink, and another quarterly earnings season rolls around. Today, it's Truist Financial Corporation (NYSE: TFC) spilling the beans on their second quarter of 2026. If you have even a passing interest in commercial banking, there's fresh data to chew over. But, let's not beat around the bush—it ain't just...

Continue Reading
RadCred Revolutionizes Payday Loans for Borrowers with Bad Credit

Updated Category News Views 203

RadCred's Innovative Approach to Payday Loans RadCred has made waves in the financial industry with the launch of its AI-driven payday loan service, specifically catering to individuals grappling with bad credit. This groundbreaking platform presents a solution that addresses the financial dilemmas many Americans face when traditional lending avenues are not an option....

Continue Reading
Stingray Karaoke Revolutionizes NIO Vehicles for European Drivers

Updated Category News Views 185

Exciting New Karaoke Feature for NIO Vehicles Stingray, well-known in the music and media industry, is excited to announce its latest partnership with NIO, a leader in smart electric vehicle technology. The launch of Stingray Karaoke in NIO vehicles across Europe is set to change the driving experience into a lively and interactive musical adventure. This feature not only...

Continue Reading
Urgent Literacy Data from Amplify Highlights Education Gaps

Updated Category News Views 197

Salient Takeaways from Amplify's Latest Literacy Findings The latest literacy data from Amplify paints a sobering picture of our K–2 readers. Only 57% of these young students are on track to meet fundamental reading benchmarks at this point in the academic year. Let that sink in for a second. What does it say about our efforts as a society? The Effects of the Pandemic...

Continue Reading